XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2018
Equity [Abstract]  
Stockholders' Equity
STOCKHOLDERS’ EQUITY
The following table summarizes the changes in stockholders’ equity (in millions):
 
 
Gilead Stockholders’ Equity 
 
Noncontrolling
Interest
 
Total Stockholders’ Equity 
 
Common Stock 
 
Additional
Paid-In
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Retained
Earnings
 
Shares
 
Amount
Balance at December 31, 2017
 
1,308

 
$
1

 
$
1,264

 
$
165

 
$
19,012

 
$
59

 
$
20,501

Net income
 
—

 
—

 
—

 
—

 
1,538

 
1

 
1,539

Other comprehensive loss, net of tax
 
—

 
—

 
—

 
(42
)
 
—

 
—

 
(42
)
Issuances under employee stock purchase plan
 
1

 
—

 
48

 
—

 
—

 
—

 
48

Issuances under equity incentive plans
 
5

 
—

 
64

 
—

 
—

 
—

 
64

Stock-based compensation
 
—

 
—

 
224

 
—

 
—

 
—

 
224

Repurchases of common stock
 
(14
)
 
—

 
(36
)
 
—

 
(1,085
)
 
—

 
(1,121
)
Dividends declared
 
—

 
—

 
—

 
—

 
(752
)
 
—

 
(752
)
Cumulative effect from the adoption of new accounting standards
 
—

 
—

 
—

 
(293
)
 
483

 
—

 
190

Balance at March 31, 2018
 
1,300

 
$
1

 
$
1,564

 
$
(170
)
 
$
19,196

 
$
60

 
$
20,651


Accumulated Other Comprehensive Income (Loss)
The following table summarizes the changes in AOCI by component, net of tax (in millions):
 
 
Foreign Currency Translation
 
Unrealized Gains and Losses on Available-for-Sale Securities
 
Unrealized Gains and Losses on Cash Flow Hedges
 
Total
Balance at December 31, 2017
 
$
85

 
$
194

 
$
(114
)
 
$
165

Net unrealized gain (loss)
 
7

 
(36
)
 
(61
)
 
(90
)
Reclassifications to net income
 
—

 
—

 
48

 
48

Reclassifications to retained earnings as a result of the adoption of new accounting standards
 
—

 
(293
)
 
—

 
(293
)
Net current period other comprehensive income (loss)
 
7

 
(329
)
 
(13
)
 
(335
)
Balance at March 31, 2018
 
$
92

 
$
(135
)
 
$
(127
)
 
$
(170
)

The amounts reclassified to net income for gains and losses on cash flow hedges are recorded as part of Product sales on our Condensed Consolidated Statements of Income. See Note 5, Derivative Financial Instruments for additional information. Amounts reclassified to net income for gains and losses on available-for-sale debt securities are recorded as part of Other income (expense), net, on our Condensed Consolidated Statements of Income.
Stock Repurchase Program
In the first quarter of 2016, our Board of Directors authorized a $12.0 billion stock repurchase program (2016 Program) under which repurchases may be made in the open market or in privately negotiated transactions. We started repurchases under the 2016 Program in April 2016.
During the three months ended March 31, 2018, we repurchased and retired 13 million shares of our common stock for $1.0 billion through open market transactions under the 2016 Program. As of March 31, 2018, the remaining authorized repurchase amount under the 2016 Program was $7.0 billion.